Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Exercise | $45.8K | SEC | |
| ExerciseD | $0 | SEC | |
| Other | $178.9K | SEC | |
| ExerciseD | $12.4K | SEC | |
| AwardD | — | SEC | |
| Buy | $990 | SEC | |
| Buy | $9K | SEC | |
| Buy | $3.5K | SEC | |
| Buy | $618 | SEC | |
| Exercise | $2.9K | SEC | |
| ExerciseD | — | SEC | |
| ExerciseD | — | SEC | |
| Exercise | $3.4K | SEC | |
| BuyD | $17.6K | SEC | |
| Buy | $22.5K | SEC | |
| BuyD | $1.1K | SEC | |
| Buy | $19.5K | SEC | |
| Buy | $1.3K | SEC | |
| Buy | $6.3K | SEC | |
| Buy | $6.2K | SEC | |
| Buy | $4.1K | SEC | |
| Buy | $6.9K | SEC | |
| Buy | $5.1K | SEC | |
| AwardD | — | SEC | |
| AwardD | — | SEC |